CTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia
|
|
- Oliver Jenkins
- 6 years ago
- Views:
Transcription
1 Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization Connect with us to connect with Asia CTS East Coast Oct 19 th, 2011 Philadelphia
2 Introduction Zuellig Pharma Asia Pacific Asia Pacific s leading distribution solutions provider for healthcare products Privately Owned (80/20) Established over 90 years Sales 2010: US$ 6.9 billion 14 countries and regions in Asia Pacific 9,000 employees
3 Introduction ZP Specialty Solutions Group Wholly owned affiliate of Zuellig Pharma Offers logistics & supply chain management solutions HQ in Singapore since 2009 Core businesses: Clinical Reach (IMP services suite) Specialty logistics for IMP and supplies Own depot network across 13 APAC countries Transport solutions (International courier and domestic) Comparator drug sourcing & labeling 1,000 clinical studies over 5 years (40% cold chain) Pharma Bio-Logistics (regional distribution of commercial drugs) Anti-counterfeit Solutions (combining serialization and SMS technology)
4 Our Network, Your Clinical Reach Features a unique network of storage Depots for IMP covering 14 locations Seoul Beijing Kobe Bangladesh Shanghai Taipei Mumbai Bangkok Hong Kong Manila Sri Lanka Kuala Lumpur Ho Chi Minh Singapore Jakarta Central Depot (2) Sydney New Zealand Local Depots (12) New Local Depots 2012 (2 planned)
5 Agenda Changing environment The role of Asia Evaluating supply chain models Case study on cost optimization Innovation in the clinical supply chain
6 The backdrop Cost pressure in R&D and demand for higher ROI greater than ever Trend to greater, more holistic collaboration Pfizer Parexel / ICON GSK Parexel / PPD BMS Parexel / ICON Eli Lilly Parexel (for Asia) Eisai Quintiles Takeda Global strategic partnership with Quintiles / Covance Sanofi A. Covance (10 year strategic deal) Merck PPD Sponsor CRO Reduced number of service partners higher contract value Shift in risk/reward sharing approach (outcome based remuneration)
7 The emerging challenge Low innovation rate in clinical trial supply chain management Is your service provider a potential liability for you? What are the incentives for logistics service providers to innovate? Is single source and volume leverage the (only) route to greater cost savings in clinical trial logistics? More dominant role of procurement Logistics? Sponsor CRO
8 What drives clinical research The Threat: Patent cliff (top-line challenge) Between , $142 bln sales of patented products face generic competition (IMS) Speed to market The Opportunity: Increased Revenue Closing gap between research and markets (e.g. Asian specific diseases) Stakeholders: Increasing regulatory requirements Larger trials required (more patients across more countries, genetic diversity) Internal: Rising cost of clinical trials & low R&D productivity High cost of drug development (est. 800M 1B USD per drug) Unsatisfactory return on R&D investment
9 The role of Asia
10 The Asian attraction Better access to patients Low clinical trial density (CT per million population) China (0.4), India (0.7), South Korea (9.5), USA(120), Germany (51) Faster recruitment rates 85% of clinical trials in traditional markets experience delays due to patient recruitment Lower costs per patient (40-60% cheaper) Asia (excluding China) is up to 60% of the cost in US/Western Europe Population with genetic, therapeutic and demographic advantage Hospitals increasingly experienced in conducting global multinational trials Talented workforce (qualified investigators and site support) Large number of drug naïve population
11 Asia's growth New Clinical Trials ( ) by region 1200 CRO Market Size in USD million (Asia) North America Europe Asia Pacific Source: Clinicaltrials.gov Growth in studies ( ): North America 55% Europe 94% Asia Pacific 95% Source: Frost & Sullivan 65% of FDA-regulated clinical trials will be conducted with sites outside of US by 2013 (
12 Evaluating Supply chain models for Asia Modifying supply chain tactics according to clinical study dynamics
13 Approaches to IMP shipment 1/3 Central Depot Model IMP source US, EU Central Depot Thailand Site 1 Site 2 Site n Advantage Relatively low IMP needed Standardized external processing Simplicity for IMP source Efficient shippers to Central Depot Centralized kitting, labeling option Taiwan Site 1 Site 2 Site n Disadvantage Highly dependent on courier service Highly dependent on shipper performance High transit risk, excursion risk High international shipment /packaging cost IMP recall, return & destruction challenging/ impossible and costly
14 Approaches to IMP shipment 2/3 Local Depot Model IMP source US, EU Advantage Local validated and efficient shippers Shortest lead time to site (same or next day) Most responsive to site orders Lowest cost (local transportation) Same time zone / language as site Recalls, returns, destruction is localized Local comparator drug sourcing option Local expiry date re-labeling saves IMP cost Disadvantage More IMP needed Forecast based supply ( recruitment) Higher depot fix cost, storage & mgmt cost Quality management/ qualification of depots Local Depot Korea Site 1 Site 2 Site n
15 Approaches to IMP shipment 3/3 Hybrid Depot Model IMP source US, EU Central Depot Thailand Site 1 Site 2 Site n Taiwan Advantage Reasonable complexity for IMP source Most adaptable, supply strategy can change during study Shortest lead time (1-3 days) to Site High responsive to Site orders Optimum cost (Inventory vs. local transport) Same time zone / language as site Suitable for adaptive trial designs and competitive recruitment strategies Disadvantage Local Depot Korea Site 1 Site 2 Site n Site 1 Site 2 Site n Complex project mgmt Forecast based supply to depot Higher depot fix cost, storage & mgmt cost
16 The ultimate supply chain challenge To do this Have the right kit at the right time at the right site in the right quality for the right patient while minimizing waste of time cost drug/materials Your supply chain needs agility to adapt to changing requirements (known) and circumstances (unknown).
17 Case study
18 Case Study Project Challenges & Key Logistics Figures Global Phase III study, 36 months 7,000 subjects (1,755 for Asia) IP (2-8 C) IP Kit valued at USD Local sourced comparator drug Return and destruction of IP at project end A surprise element unknown to all parties at time of RFQ. Several states 7 countries Indonesia Malaysia Philippines Singapore Taiwan
19 Case Study Key Transaction Figures 2 inbound per year 12 outbound per site 1 return per site No. of sites by country: Malaysia 5 Philippines 20 Indonesia 2 Taiwan 15 Singapore 3 Central Depot (benchmark) Taipei Hybrid Model (alternative) 387,000 USD Thailand Manila 240,000 USD Malaysia Singapore Indonesia
20 Case Study Key Transaction Figures 2 inbound per year 12 outbound per site 1 return per site No. of sites by country: Malaysia 5 Philippines 20 Indonesia 2 Taiwan 15 Singapore 3 Central Depot (benchmark) 387,000 USD Courier -146,000 Additional IP (20%) + 42,000 Packaging Box - 36,000 Project Mgmt + 19,000 Return/destruct. - 12,000 Hybrid Model (alternative) 240,000 USD Other Benefits Local comparators saved additional USD 55,000 (drug, transport & duties) 3 depots managed by single provider for Asia PH, TW: Re-usable shipping containers (no disposal at sites needed) Zero IP loss due to temperature excursion (no hidden cost) No complications with project close-out (returns & destruction)
21 The Project Manager s Office
22 May 6 th, 2011 The surprise element arrives 약사법시행규칙 75 조 ( 의약품의표시및기재사항 ) 6 법제 56 조각호외의부분단서에따라임상시험용의약품의용기나포장에는다음각호의사항을기재하여야한다. 다만, 법제 31 조제 2 항및제 3 항또는법제 42 조제 1 항에따른허가를받지아니하거나신고를하지아니한사항은기재하지아니한다. " 임상시험용 " 이라는표시 제품의코드명또는주성분의일반명 제조번호및사용 ( 유효 ) 기한또는재검사일자 저장방법 임상시험계획승인을받은자의상호와주소
23 Translation Announcement of regulatory change issued on 6. May 2011 According to the revised Pharmaceutical Affair Law 56, IND holder s name and address has to be included on each pack of IMP. (Effective date: 6. May 2011 ) Investigation medicinal products Product code of general name of API Batch no and expiry date or retest date How to store / storage condition IND holder s name and address IND (investigational new drug)
24 ... Effect I don t like to hear about problems, I want solutions!
25 ... The solution 16 customers using that depot representing 35 sponsors affecting 200 studies requiring 85,000 kits at the depot to be re-labeled How we solved the problem: we printed label locally we provided a local GMP compliant labeling service we ensured there were no disruptions to IP supplies to sites all for a bargain of just USD 0.65/IP kit. 5 months later Still, most incoming shipments are received non-compliant. IP either already manufactured or it is easier to apply label in Korea than change the label at source. Key conclusion: Working with the right vendor is the key to being able to respond to unexpected local challenges and to have flexibility.
26 Innovation in the clinical supply chain
27 Eye on innovation Versatile supply chain models as driver of cost avoidance Biological specimen collection process (consolidation & packaging) Tax & duty recovery for IP that has been destroyed Simplified fee structure
28 Summary Asia s role is increasing and Asian countries are becoming more frequently part of US FDA controlled clinical trials. To harness greater cost saving opportunities, supply chain models and execution will need to become more sophisticated. Assess with an open mind the viability of new emerging solutions alternatives and scrutinize current alliances to ensure continued value creation through innovation.
29 Thank you!
Pharmaceutical Product Development NASDAQ: PPDI. Dan Darazsdi Chief Financial Officer. Credit Suisse Healthcare Conference November 2009
Pharmaceutical Product Development NASDAQ: PPDI Dan Darazsdi Chief Financial Officer Credit Suisse Healthcare Conference 2009 12 November 2009 Safe Harbor Except for historical information, all of the
More information1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and
1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and Development Market in Asia - Overview 3.1 Introduction 3.1.1
More informationTrends. Economy and talent Outsourcing industry challenges. June Mercer
Trends Economy and talent Outsourcing industry challenges June 2011 0 Talent insights Talent shortage in the northern hemisphere Baby boomers retiring Employability issue in the southern hemisphere Only
More informationManaging T&E Indirect Contracts in Asia Pacific. Issa Isaac Director, Global Service, Asia Pacific
Managing T&E Indirect Contracts in Asia Pacific Issa Isaac Director, Global Service, Asia Pacific Asia Pacific East vs. West Opinion A A B B Contacts Traveling Handling of Problems The Boss Pakistan China
More informationFEBRUARY 2015 D. Lee Spurgin, Jr., PhD
FEBRUARY 2015 D. Lee Spurgin, Jr., PhD Resources - Publications Little Advisor ICH-GCP, Investigational Site - English Little Advisor ISO 14155:2011, Sponsor Responsibilities - English Little Advisor ISO
More informationGlobal IT Procurement and Logistics. Simplifying the complex: an end-to-end IT supply chain solution
Global IT Procurement and Logistics Simplifying the complex: an end-to-end IT supply chain solution We make the complex simple Managing an international IT supply chain isn t an easy task, and comes with
More informationAsia A New Frontier for Clinical Research and Development
Asia A New Frontier for Clinical Research and Development Executive Summary As the pharmaceutical market experiences rapid growth in Asia, more clinical trials are being conducted in the region, offering
More informationCHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS
Clinical Trial Supply 28 th 29 th October 2014 Princeton, NJ - USA CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS 1 Agenda The challenges associated with various
More informationTop 10 Questions to Ask Your Clinical Supply Vendor about Temperature Sensitive Drugs
Cold Chain Supply: Top 10 Questions to Ask Your Clinical Supply Vendor about Temperature Sensitive Drugs fisherclinicalservices.com Table of Contents Introduction...1 Special Considerations for Investigational
More informationINTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES
WHITE PAPER INTRODUCTION TO MODERN RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SERVICES Randomization is fundamental to clinical trials it enables treatment group balance, eliminates selection bias and limits
More informationOVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS IN EMERGING MARKET
Badjatya et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 227-232 227 Available online at http://jddtonline.info REVIEW ARTICLE OVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS
More informationAN ALLIANCE WHERE AIRLINES TRUST IN
AN ALLIANCE WHERE AIRLINES TRUST IN INTRODUCTION Message from Group CEO WAG group is Asia s largest GSA alliance network preferred by airlines in a highly complex and competitive market. Network cooperation
More informationWHITE PAPER. establishing a regulatory Drug Development Strategy for Asia Pacific
WHITE PAPER establishing a regulatory Drug Development Strategy for Asia Pacific ppdi.com July 2012 EXECUTIVE SUMMARY As the economic power of China and other Asian countries grows, many biopharmaceutical
More informationASIA PACIFIC ADVERTISING TRENDS
ASIA PACIFIC ADVERTISING TRENDS March 2018 Executive Summary 1-50 Regional Summary 5-6 Sources And Methodology 7 Regional Overview 8-15 Net Advertising In Asia Pacific 8 Advertising Y/Y Growth By Segment
More informationCHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics
CHINA. Bio & Pharma Logistics Andrew McDonald Operations Director, Asia Pacific Melbourne, Australia, 27th March 2013 Australia - China Life Science Summit Responsibilities Who takes responsibility on
More informationRole of Data Privacy on International Business: Innovating for Consistency Within Regions & Beyond
Role of Data Privacy on International Business: Innovating for Consistency Within Regions & Beyond GSMA Data Protection and Privacy Conference Kuala Lumpur August 2013 Rob Borthwick Axiata Group Berhad
More informationGlobal Development in Chinese Taipei. Oct. 13, 2006 Herng-Der Chern, M.D., Ph.D. Executive Director Center for Drug Evaluation, Chinese Taipei
Global Development in Chinese Taipei Oct. 13, 2006 Herng-Der Chern, M.D., Ph.D. Executive Director Center for Drug Evaluation, Chinese Taipei Pharmaceutical Market of Asia Market Size (Million USD) Expenditure
More informationASIA PACIFIC ADVERTISING TRENDS
ASIA PACIFIC ADVERTISING TRENDS April 2017 Table of Contents Executive Summary 1-24 Sources And Methodology 3 Overview 4-8 Asia Pacific Advertising Revenue (US$ mil.) 5 Asia Pacific Advertising Market
More informationBio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies
Global Strategy Global Challenges Executable Solutions Bio-Pharma: China 2010-2020 A Look at The FUTURE: 4 th & 5 th Generation Global Strategies France Houdard Managing Director January 2010 Table of
More informationGlobal Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research
Transparency Market Research Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Buy Now Request Sample Published Date: April 2014 Single User License: US
More informationRegional Workshop on the Environmentally Safe Disposal of Intellectual Property-Infringing Goods
A/P Regional Workshop on the Environmentally Safe Disposal of Intellectual Property-Infringing Goods IPR Capacity Building in Asia Pacific Region Disposal of Goods from the Customs Perspective in the Asian
More informationConstruction Automotive Industry.
Rehau HYBRID plumbing system THE ULTIMATE COMBINATION www.rehau.com Construction Automotive Industry REHAU HYBRID A NEW APPROACH TO PLUMBING The REHAU Hybrid system combines the strengths of both the PEX
More informationEnsuring Supply Chain Performance and Agility During a Period of Integration and Change
Ensuring Supply Chain Performance and Agility During a Period of Integration and Change Martin McLoughlin Director, Supply Planning & Systems Merck October 19, 2011 Philadelphia, PA Today s Presentation
More informationAsia Pacific. Patrick Williams. Senior Vice President, APAC Autodesk
Asia Pacific Patrick Williams Senior Vice President, APAC Mumbai Delhi Bangalore Pune Beijing Wuhan Chengdu Hanoi Bangkok Kuala Lumpur Ngee Ann City Guangzhou Sin Ming Seoul Tokyo Osaka Shanghai Taipei
More informationConsiderations for Global Development of Orphan Drugs. Ginny Beakes-Read Executive Director Global Regulatory Policy and Intelligence Eisai, Inc.
Considerations for Global Development of Orphan Drugs Ginny Beakes-Read Executive Director Global Regulatory Policy and Intelligence Eisai, Inc. 1 Disclosures Shareholder No Grant/research support No Consultant
More informationCounterfeit Drugs and Supply Chain Security
Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children
More informationSection. Clinical CRO Future Industry Leadership & Performance Benchmarking. October, Syndicated Report
Section Clinical CRO Future Industry Leadership & Performance Benchmarking Syndicated Report October, 2015 1 Table of Contents I. Study Background and Methodology 3 II. Study Respondent Demographics 6
More informationWHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges
WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and
More informationEnhancing competitiveness in a transforming pharmaceutical industry. Is your business ready to accelerate?
Enhancing competitiveness in a transforming pharmaceutical industry Is your business ready to accelerate? An industry in transformation The pharmaceutical industry is undergoing unprecedented transformation
More informationTrue Global Reach. Single Source. Compliance. Security. Value Recovery.
True Global Reach. Single Source. Compliance. Security. Value Recovery. Peran TES-AMM Indonesia dalam Extended Producer Responsibility (EPR) Seminar Pendekatan EPR dalam Mengurangi Penyebaran PBDE pada
More informationGlobal Shipping and Logistics
Global Shipping and Logistics We re here to help from start to finish wherever you need to go. 2017.12.V01 Wherever you are, wherever you need to be At Myriad, we recognize that managing an international
More informationMotorization and Environmental Problem in Asia Kiyoyuki Minato Japan Automobile Research Institute
2008.11.2 JARI JBIC-LPEM Workshop in Jakarta Motorization and Environmental Problem in Asia Kiyoyuki Minato Japan Automobile Research Institute 1 Contents 1. Japanese Environmental Policy 2. Motorization
More informationSpeed Innovation Happiness. Services Overview
Services Overview Bilcare GCS Objective To Provide Reliable and Credible Long-term Clinical Trial Material Supplies Partnering with Global Sponsor/CRO to successfully conduct the Clinical Trials, Worldwide
More informationRadiopharmaceuticals overview of requirements
Radiopharmaceuticals overview of requirements Did you know? That Australia has a research nuclear reactor producing nuclear medicine 1 in 2 Australians will receive some kind of nuclear medicine in their
More informationFinding the Balance between Clinical & Commercial Key Roles. Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan
IBC LIFE SCIENCES Part of: 4 TH ANNUAL Grand Copthorne Waterfront Hotel, Finding the Balance between Clinical & Commercial Key Roles Expert Faculty Include: Ajay Tiku Vice President Medical, Asia Pacific,
More informationWORKFORCE METRICS BENCHMARK REPORT
WORKFORCE METRICS BENCHMARK REPORT THE MORE YOU KNOW, THE SMARTER YOU WORK As an HR professional, you focus on helping your organization optimize its human capital, but how do you show that achievement?
More informationCargo Sales & Service Presentation. Air Logistics Group
Cargo Sales & Service Presentation Air Logistics Group Air Logistics Group Introduction Introducing Air Logistics Group IATA Approved Over $450m cargo sales 280 employees worldwide Experienced management
More informationWorld Medical Tourism Market - Opportunities and Forecasts,
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > World Medical Tourism Market - Opportunities and Forecasts, 2015-2022 World Medical Tourism Market - Opportunities
More informationGrowing opportunity, growing business. EY s financial services practice in ASEAN
Growing opportunity, growing business EY s financial services practice in ASEAN Our team of almost 3,900 financial services professionals across Asia-Pacific and close to 1,700 in ASEAN connects to bring
More informationThe Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time
The Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time Clinical Trial Supply Southeast 2015 July 15 th July 16 th RTP, North Carolina Presenters: Eva Allen Heather Phillips
More informationAsia Pacific Economic Co-operation (APEC) Principles for voluntary codes of business ethics
Asia Pacific Economic Co-operation (APEC) Principles for voluntary codes of business ethics Chrisoula Nikidis Executive Director, Ethics and Compliance, Rx&D Canada The Asia-Pacific Pharmaceutical Compliance
More informationThe best way you can manage your global relocation, transportation & logistics needs. Together.
The best way you can manage your global relocation, transportation & logistics needs Together. Who we are $2.2 billion UniGroup Global Transportation & Relocation Solutions The best names in moving, using
More informationThe Lessons from Indonesia
The Lessons from Indonesia Dr. Brian W Tempest www.briantempest.com Brian.tempest@clara.co.uk Kuala Lumpur, Malaysia 29 th April 2010 The Lessons from Indonesia Indonesia Visit Dates March 7-12 2010 Case
More informationAustralia: A Dynamic Environment for Conducting Clinical Trials
Australia: A Dynamic Environment for Conducting Clinical Trials MTPConnect s goal is to accelerate the growth of Australia s MTP sector Industry Associations Governments Universities Researchers Investors
More informationA world in transition: PwC s 2017 APEC CEO Survey, November APEC CEO Survey. Indonesia findings.
A world in transition: PwC s 2017 APEC CEO Survey, November 2017 2017 APEC CEO Survey Indonesia findings www.pwc.com/apec Key themes Making of the workforce of the future An operating model for a fluid
More informationUPS Healthcare Supply Chain Vital Signs
UPS Study Executive September 2017 START 2017 UPS Survey 2017 United Parcel Service of America, Inc. 1 An industry growing more complex: managing competition, compliance and costs Pharmacies are grappling
More informationEmerging Trends in Regulatory Outsourcing WHITE PAPER.
WHITE PAPER www.makrocare.com/consulting You are not alone in the quest for bringing your products to market and improve the quality of the life for millions! MakroCare brings you the insight on how a
More informationDelivering a Sustainable Energy Future for the World
5th National Energy Forum - Malaysia 3 September 2013 Delivering a Sustainable Energy Future for the World Ralph D. Samuelson Asia Pacific Energy Research Centre (APERC) APEC Member Economies From APEC
More informationValuation of Biosimilar and Key Value Drivers Dr. Patrik Frei October 2015 Biosimilars Asia
Valuation of Biosimilar and Key Value Drivers Dr. Patrik Frei October 0 Biosimilars Asia Agenda Introduction Valuation of Biosimilar Key Value Driver / Conclusion Venture Valuation Independent assessment
More informationCold-Chain & Logistical Challenges of Cell Therapeutics in Clinical Trials
Cold-Chain & Logistical Challenges of Cell Therapeutics in Clinical Trials Dan O Donnell Associate Director, Cell Therapy Logistics Fisher BioServices Part of Thermo Fisher Scientific Logistics of Biologics
More informationIndonesian Logistics Overview
Indonesian Logistics Overview YUKKI NUGRAHAWAN HANAFI Chairman Member of : 15 Packages of Economic Policies 9 Sept 2015 Package 1 Improvement of industrial competition level 27 Jan 2016 Package 9 Electricity
More informationChina Versus India. By Ling Li, Lan Kang and Shilpa Gentela. China v. India
China Versus India Reality Check FOR PHARMA R&D China v. India n MNC Commitment Differs According to Tax and Other Policies to Lure FDI n n China s Infrastructure Better Due to Government Commitment India
More informationGlobal Supply Chain Management. Ecosystem Aware. Performance Analysis. N. Viswanadham
Performance Analysis N. Viswanadham Contents l Global Supply Chain Performance l Lead Time l Cost l Performance Measures & Ecosystem Global Supply Chain Ecosystem Aware China Supplier Supplier India Suppliers
More informationIndian Pharmaceutical Industry. January 2018
Indian Pharmaceutical Industry January 2018 Introduction The pharmaceutical Industry around the world is one of the fastest growing industries and a major contributor to the world economy. 2020 55 1400
More informationHOW BUSINESS AND ORGANIZATIONS AROUND THE WORLD ARE ADDRESSING THE WATER STEWARDSHIP AGENDA
HOW BUSINESS AND ORGANIZATIONS AROUND THE WORLD ARE ADDRESSING THE WATER STEWARDSHIP AGENDA 3 rd Karachi International Water Conference Adrian Sym, CEO, Alliance for Water Stewardship November 21 st, 2017
More informationStrategic vision of Pharma Market
Strategic vision of Pharma Market Evolution 2012-2016 ACIP Presentation, Paris January 30, 2013 Introduction This presentation draws strategic orientations for pharma companies considering the expected
More informationMizuho Economic Outlook & Analysis The 16 th Questionnaire Survey of Japanese Corporate Enterprises Regarding Business in Asia (February 2016)
Mizuho Economic Outlook & Analysis The 16 th Questionnaire Survey of Japanese Corporate Enterprises Regarding Business in Asia (February 16) May 16 Copyright Mizuho Research Institute Ltd. All Rights Reserved.
More informationRBM Risk Based Monitoring GCP Training 12/SEP/2015. Gabor Kiss Synexus Hungary2015
RBM Risk Based Monitoring GCP Training 12/SEP/2015 Gabor Kiss Synexus Hungary2015 Agenda Why traditional monitoring must change? The landscape Regulatory Industry IT What can we expect? Transition period
More informationShipping to Korea. Company Portrait
Shipping to Korea Company Portrait HISTORY 1980 1985 2006 2007 2014 FIRST COURIER COMPANY IN KOREA EXPANSION OF BRANCHES OWN WAREHOUSES E-COMMERCE BUSINESS EXPANSION FIRST COURIER COMPANY ESTABLISHED BY
More informationIntroduction and Background of the ILSI Japan/MAFF Project
International Conference on Infrastructure Needs for a Food Control System: Roadmap for Regional Harmonization Introduction and Background of the ILSI Japan/MAFF Project December 9, 2014 New Delhi, India
More informationHospira 2007 Investor Day. APAC Region. Tim Oldham, Ph.D. President, Asia-Pacific. Advancing Wellness. through the right people and the right products
Hospira 2007 Investor Day APAC Region Tim Oldham, Ph.D. President, Asia-Pacific Advancing Wellness through the right people and the right products The APAC Region Asia in Brief: 58% of the world s population
More informationA New Approach to Outsourced Drug Development:
A New Approach to Outsourced Drug Development: How Sponsor-CRO Clinical Delivery Alliances Improve Performance Therapeutic Foresight. Trusted Results. Page 2 A New Approach to Outsourced Drug Development:
More informationLNG in the Asia Pacific
2016/EWG52/WKSP1/004 LNG in the Asia Pacific Submitted by: APERC Asia Pacific Energy Research Centre Workshop Moscow, Russia 18 October 2016 APERC Workshop at EWG52 Moscow, Russia, 18 October, 2016 3-2.
More informationBRIC Plus. Uncovering economic and supply chain success in the new emerging economies. David Jacoby. (1)
BRIC Plus Uncovering economic and supply chain success in the new emerging economies David Jacoby www.bostonstrategies.com (1) 781-250-8150 Agenda BRIC and Other Country Clusters The Next Generation Emerging
More informationConsiderations When Using Advanced Packaging Materials Richard Wood Design Manager, Peli BioThermal
Considerations When Using Advanced Packaging Materials Richard Wood Design Manager, Peli BioThermal 1 Peli BioThermal A Brief History 2 Presentation Overview Methods for selecting the most appropriate
More informationOvercoming the Hurdles in Emerging Markets, a Panel Discussion
Overcoming the Hurdles in Emerging Markets, a Panel Discussion Because life depends on us TM, the Bio Supply Management Alliance supports continuous learning and improvement of bio supply management professionals
More informationProposal for Improving the Business Environment in Lao PDR - Based on a JETRO survey on business needs -
Proposal for Improving the Business Environment in Lao PDR - Based on a JETRO survey on business needs - July 4, 2015 Japan External Trade Organization (JETRO) Promote Good Connectivity with Neighboring
More informationInternational Conference and Exhibition on Drug Processing, Labeling & Packaging
(Theme: Encounter Innovations in Pharma Labeling, Packaging and Innovative in Drug Processing) About the Conference: Drug Packaging-2015 welcomes attendees, presenters, and exhibitors from all over the
More informationU.S. Hospitals Study Executive Summary
UPS Healthcare Study Executive September 2017 START 2017 Survey 2017 United Parcel Service of America, Inc. 1 An industry facing disruptive change: managing consumerization, clinical outcomes and costs
More informationLife Sciences & Pharmaceuticals Conference - LHR November Bourji Mourad Global Head Partner Management
Life Sciences & Pharmaceuticals Conference - LHR 22 23 November 2016 Bourji Mourad Global Head Partner Management 1 Envirotainer a short Introduction Healthcare Market Trends Visibility Cost 2 Envirotainer
More informationCold Chain A case study. Dan Gourley Director of Global Clinical Logistics September 30 th, 2011
Cold Chain A case study Dan Gourley Director of Global Clinical Logistics September 30 th, 2011 Agenda Summary of study Review ship to countries Import/Export of supplies Cold Chain Packaging Packaging
More informationAmgen Supply Chain Segmentation The Journey to October 23, 2014
Amgen Supply Chain Segmentation The Journey to 2022 October 23, 2014 Introduction Rayne Waller VP Global Supply Chain at Amgen Responsible for: Corporate and Regional Supply Chain Functions Contract Manufacturing
More informationVISIONARY SCIENCE GLOBAL RESEARCH UPDATE 2015 QUARTER 4
2015 QUARTER 4 Frost & Sullivan s Visionary Science research group delivers strategic and actionable insights and analysis covering all aspects of the industry including technologies, econometrics, applications,
More informationYokogawa Engineering Asia
2008 Frost & Sullivan Asia Pacific Industrial Technologies Awards DCS Company of the Year Yokogawa Engineering Asia The 2008 Frost & Sullivan Asia Pacific Company of the Year Award for Distributed Control
More informationHR Technology Collaboration. = Productivity n. PPT File 2016 Faro Recruitment. All rights reserved.
HR Technology Collaboration = Productivity n Evolution of Technology We are in the time of Transformation Video Sharing https://www.youtube.com/watch?v=prsuuwectbm I can see why computers now they have
More informationKey Considerations in Payroll Management: The View from APAC
Key Considerations in Payroll Management: The View from APAC 2 1 Executive Summary An effective payroll management strategy provides far reaching benefits to an organization by improving employee satisfaction,
More informationKey Considerations in Payroll Management: The View from APAC
Key Considerations in Payroll Management: The View from APAC 2 1 Executive Summary An effective payroll management strategy provides far reaching benefits to an organization by improving employee satisfaction,
More informationDesigning your supply chain as accurately as possible based on thorough product testing
Designing your supply chain as accurately as possible based on thorough product testing Virginie ROUX Sanofi R&D Clinical Supplies Scientific Core Platform Agenda I. Our organization II. Adaptability to
More informationGlobalization and urban environmental change in the Asia Pacific Region
UN DESA International workshop on Global urbanization, internal migration, population distribution and development 21-23 January 2008 Globalization and urban environmental change in the Asia Pacific Region
More informationDelivering a Comprehensive Serialization Traceability Program GS1 Global Conference 21 Oct 2015 Peggy Staver - Pfizer
Delivering a Comprehensive Serialization Traceability Program GS1 Global Conference 21 Oct 2015 Peggy Staver - Pfizer Overview Pfizer History What it Takes Strategies Organization Solutions Business-as-Usual
More informationWHITE PAPER 5 TIPS FOR MANAGING FOOD AND BEVERAGE SUPPLY CHAIN
WHITE PAPER 5 TIPS FOR MANAGING FOOD AND BEVERAGE SUPPLY CHAIN CONTENT AUTOMATE, AUTOMATE, AUTOMATE... 1 PLAN FOR FUTURE DEMAND... 2 MAINTAIN DETAILED REGULATORY COMPLIANCE DATA... 3 CONTROL COSTS BY MINIMIZING
More informationTalent Solutions. APAC Talent Pool Reports Q Where you can find top talent and more
Talent Solutions APAC Talent Pool Reports Q1 2014 Where you can find top talent and more Table of Contents Banking and General Finance Construction Corporate Finance Logistics and Supply Chain Management
More informationClinical Trial Supplies. Establishing Firm Grounds for your Trials
Clinical Trial Supplies Establishing Firm Grounds for your Trials Clinical Trial Logistics & Supplies The success of a clinical trial largely depends on its conduct, data management, statistical analysis
More informationLogistics Management
Logistics Management Dr.T.A.S.Vijayaraghavan XLRI, Jamshedpur Logistics The branch of military science and operations dealing with the procurement, supply and maintenance of equipment, with the movement,
More informationOcean Market Update. February 9, 2012
Ocean Market Update February 9, 2012 Agenda 2012/2012 Market Trends Status of EB TP Capacity Changes In Alliances Conclusions Photo placeholder 2 Global box container trade growth 2011 (Oct YTD): 7.1%
More informationDrug Registration in BRICS countries: Opportunities and Challenges. Judith ter Horst 1 November 2018
Drug Registration in BRICS countries: Opportunities and Challenges Judith ter Horst 1 November 2018 Once a drug reaches Phase1, it s a good idea to start discussions with global regulatory authorities
More informationGMX (Pvt) Ltd. Profile. International Express Courier. Dear Sir/Madam AOA,
Dear Sir/Madam AOA, Kindly find the GMX (Pvt) Ltd. PROFILE as below, for your kind consideration and hope full for a +ive response. GMX (Pvt) Ltd. Profile GMX (Pvt) Ltd. is among the leaders in providing
More information3-2. LNG in the Asia-Pacific
APERC Workshop at EWG52 Moscow, Russia, 18 October, 2016 3-2. LNG in the Asia-Pacific Favoring trade and rational market development Kirsten Smith Researcher, APERC Report Highlights Report Highlights
More informationForging an agile, secure supply chain
Life Sciences Of special interest to Chief operating officers Chief risk officers Vice presidents of tax Insights for 5executives Forging an agile, secure supply chain The case for combining performance
More informationand Office of Hazard Identification & Reduction March 2010
Regulated Product Testing and Certification U.S. Consumer Product Safety Commission Office of Hazard Identification & Reduction March 2010 These comments are those of CPSC staff, have not been reviewed
More informationClinical Trials: Facts and Trends. Dr Nik Nikitin. Founder/Director, Russlan Clinical. ManxBioMed Annual Bio Business Conference 10 th December 2013
Clinical Trials: Facts and Trends Dr Nik Nikitin Founder/Director, Russlan Clinical What is a clinical trial? A clinical trial is a research study in human volunteers to answer specific health questions
More informationTRACK 2 Increasing Demand Visibility in Clinical Supply Chain Forecasting
Driving Innovation and Technology in the Bio-pharma Supply Chain TRACK 2 Increasing Demand Visibility in Clinical Supply Chain Forecasting Jason Dean Director of Product Management Bracket Global Science.
More informationHurdling the Stumbling Blocks in Clinical Trial Supply Innovative Technology & Tactics
Hurdling the Stumbling Blocks in Clinical Trial Supply Innovative Technology & Tactics Featuring industry experts from: Novo Nordisk PPD A/S Amgen LTD Sanofi 1 The supply of clinical trials is the one
More informationMultiple Sclerosis Treatment Market Research Report - Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/940 Multiple Sclerosis Treatment Market Research Report - Global Forecast till 2023 Report / Search Code: MRFR/HC/0434-HCRR
More informationScanwell Logistics Far and away your best move
Scanwell Logistics Far and away your best move TM Air Service Logistics Service Ocean Service Introduction About Scanwell Scanwell Logistics is one of the leading companies in global logistics industry.
More informationGlobal Track & Trace requirements for better and safer Healthcare
Global Track & Trace requirements for better and safer Healthcare Ulrike Kreysa, VP Healthcare, GS1 Global Office Riyadh, 6 th December 2016 Counterfeiting - The Impact According to Interpol more than
More informationFinancial results Q1 FY2018/19. 3 August 2018
Financial results Q1 FY2018/19 3 August 2018 Disclaimer The following presentation contains forward looking statements by the management of Singapore Post Limited ( SingPost ) relating to financial trends
More informationNatalia Nayanova Director of Clinical Operations and General Manager. Accell Clinical Research 2016
Natalia Nayanova Director of Clinical Operations and General Manager Accell Clinical Research 2016 PRESENTATION STRUCTURE Company overview Advantages of the Region FDA & EMA Acceptance Myths vs. Realities
More informationFinding the right partner for preclinical into phase I. Facts, Threats & Opportunities
Nuvisan Presentation Outsourcing and Clinical Trials DACH, 9th October 2018 Finding the right partner for preclinical into phase I Facts, Threats & Opportunities 9 October 2018 1 PASSIONATE PEOPLE FOR
More informationAPAC Harmonization: New Activities
APAC Harmonization: New Activities CMC Strategy Forum Japan 2013 December 09, 2013 Japan Pharmaceutical Manufacturers Association (JPMA) Kozo Akasaka 1 Agenda 0. What is APAC? 1. Collaboration of JPMA
More information